Do Traders Think Lyra Therapeutics Inc (LYRA) Can Keep Climbing Tuesday?

The market has been high on Lyra Therapeutics Inc (LYRA) stock recently. LYRA gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Lyra Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on LYRA!

See Full LYRA Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With LYRA Stock Today?

Lyra Therapeutics Inc (LYRA) stock is unmoved 0% while the S&P 500 has fallen -0.24% as of 4:00 PM on Monday, Sep 11. LYRA is unmoved $0.00 from the previous closing price of $4.28 on volume of 2,473,579 shares. Over the past year the S&P 500 has gained 8.91% while LYRA has fallen -30.41%. LYRA lost -$1.59 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Lyra Therapeutics Inc click here.

More About Lyra Therapeutics Inc

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Click Here to get the full Stock Report for Lyra Therapeutics Inc stock.